Inventor · disambiguated record
Clarence Frank Bennett
Also filed as: BENNETT CLARENCE F · BENNETT CLARENCE FRANK
18 granted patents·2 pending applications·1,200 citations·filing 1991–2004
95Inventor score
Files withISIS PHARMACEUTICALS INC15BAYLOR COLLEGE MEDICINE1BENNETT CLARENCE FRANK1ISIS PHARMACUTICALS INC1NOVARTIS AG1
Top patents by PatentIndex Score
20 records- 0198US6395492B1Derivatized oligonucleotides having improved uptake and other propertiesISIS PHARMACEUTICALS INC·Filed 2000·Granted May 28, 2002·234 cites·9 claims
- 0297US6753423B1Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammalsISIS PHARMACEUTICALS INC·Filed 2000·Granted Jun 22, 2004·88 cites·7 claims
- 0395US6153737ADerivatized oligonucleotides having improved uptake and other propertiesISIS PHARMACEUTICALS INC·Filed 1992·Granted Nov 28, 2000·460 cites·34 claims
- 0494US6919439B2Derivatized oligonucleotides having improved uptake and other propertiesISIS PHARMACEUTICALS INC·Filed 2002·Granted Jul 19, 2005·34 cites·12 claims
- 0594US6831166B2Derivatized oligonucleotides having improved uptake and other propertiesISIS PHARMACEUTICALS INC·Filed 2002·Granted Dec 14, 2004·34 cites·10 claims
- 0690US5510239AOligonucleotide modulation of multidrug resistance-associated proteinISIS PHARMACEUTICALS INC·Filed 1993·Granted Apr 23, 1996·100 cites·6 claims
- 0788US5744460ACombination for treatment of proliferative diseasesNOVARTIS AG·Filed 1996·Granted Apr 28, 1998·89 cites·12 claims
- 0883US5530114AOligonucleotide modulation of arachidonic acid metabolismISIS PHARMACEUTICALS INC·Filed 1991·Granted Jun 25, 1996·46 cites·1 claims
- 0979US7235650B2Derivatized oligonucleotides having improved uptake and other propertiesISIS PHARMACEUTICALS INC·Filed 2002·Granted Jun 26, 2007·4 cites·10 claims
- 1076US5656743AOligonucleotide modulation of cell growthBAYLOR COLLEGE MEDICINE·Filed 1994·Granted Aug 12, 1997·66 cites·4 claims
- 1171US7122649B2Derivatized oligonucleotides having improved uptake and other propertiesISIS PHARMACEUTICALS INC·Filed 2004·Granted Oct 17, 2006·4 cites·7 claims
- 1264US7125975B2Derivatized oligonucleotides having improved uptake and other propertiesISIS PHARMACEUTICALS INC·Filed 2004·Granted Oct 24, 2006·4 cites·6 claims
- 1362US8153602B1Composition and methods for the pulmonary delivery of nucleic acidsBENNETT CLARENCE FRANK·Filed 1999·Granted Apr 10, 2012·26 cites·11 claims
- 1457US6399376B1Modulation of vascular cell adhesive molecule expression through oligonucleotide interactionsISIS PHARMACEUTICALS INC·Filed 1993·Granted Jun 4, 2002·10 cites·8 claims
- 1550US2004142899A1Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammalsISIS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1646US2003191075A1Method of using modified oligonucleotides for hepatic deliveryFiled 2002·Application pending·0 cites
- 1733US5807838AOligonucleotide modulation of multidrug resistance-associated proteinISIS PHARMACEUTICALS INC·Filed 1994·Granted Sep 15, 1998·1 cites·28 claims
- 1831US6713621B1Chimeric oligonucleotides for modulating gene expressionISIS PHARMACEUTICALS INC·Filed 1995·Granted Mar 30, 2004·0 cites·9 claims
- 1930US6225293B1Methods and compounds for tracking the biodistribution of macromolecule-carrier combinationsISIS PHARMACEUTICALS INC·Filed 1998·Granted May 1, 2001·0 cites·27 claims
- 2023US5814619AOligonucleotide inhibition of P120ISIS PHARMACUTICALS INC·Filed 1994·Granted Sep 29, 1998·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Clarence Frank Bennett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →